01.08.2007 | ORIGINAL ARTICLE
Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers
Erschienen in: International Journal of Clinical Oncology | Ausgabe 4/2007
Einloggen, um Zugang zu erhalten